Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Making invisible cancers visible: A new route to turn 'cold' tumors 'hot' | 0 | 7.83 | 17-09-2026 |
| 2 | Scientists reveal what damages the DNA in most prostate cancers | 0 | 9 | 10-09-2026 |
| 3 | How missing pieces of the Y chromosome drive cancer in men | 0 | 8.84 | 28-09-2026 |
| 4 | На дне Чукотского моря ученые нашли средство, которое поможет в борьбе с раком | 0 | 9.47 | 01-10-2026 |
| 5 | Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer | 0 | 7.48 | 23-09-2026 |
| 6 | See the secret to DNA hookups | 0 | 11.16 | 25-09-2026 |
| 7 | Natural protein discovery may help predict and slow aggressive cancers | 0 | 6.86 | 07-07-2026 |
| 8 | Российские ученые работают над персонализированными лекарствами от рака | 0 | 6.01 | 30-09-2026 |
| 9 | Онколог Каприн предостерег от поисков способов лечения рака в интернете | 0 | 10 | 01-10-2026 |
| 10 | New research maps immune events in early stages of lung fibrosis | 0 | 5.7 | 24-08-2026 |